1. Smolen, J. S.; Aletaha, D.; McInnes, I. B., Rheumatoid arthritis. The Lancet 2016, 388, (10055), 2023-2038.
2. Ha, Y. J.; Lee, S. M.; Mun, C. H.; Kim, H. J.; Bae, Y.; Lim, J. H.; Park, K. H.; Lee, S. K.; Yoo, K. H.; Park, Y. B., Methotrexate-loaded multifunctional nanoparticles with near-infrared irradiation for the treatment of rheumatoid arthritis. Arthritis research & therapy 2020, 22, (1), 146.
3. Yang, Y.; Ye, Y.; Qiu, Q.; Xiao, Y.; Huang, M.; Shi, M.; Liang, L.; Yang, X.; Xu, H., Triptolide inhibits the migration and invasion of rheumatoid fibroblast-like synoviocytes by blocking the activation of the JNK MAPK pathway. International immunopharmacology 2016, 41, 8-16.
4. Li, Y.; Wang, J.; Xiao, Y.; Wang, Y.; Chen, S.; Yang, Y.; Lu, A.; Zhang, S., A systems pharmacology approach to investigate the mechanisms of action of Semen Strychni and Tripterygium wilfordii Hook F for treatment of rheumatoid arthritis. Journal of ethnopharmacology 2015, 175, 301-14.
5. Zhou, Z. L.; Yang, Y. X.; Ding, J.; Li, Y. C.; Miao, Z. H., Triptolide: structural modifications, structure-activity relationships, bioactivities, clinical development and mechanisms. Natural product reports 2012, 29, (4), 457-75.
6. Li, P.; Yang, X.; Yang, Y.; He, H.; Chou, C. K.; Chen, F.; Pan, H.; Liu, L.; Cai, L.; Ma, Y.; Chen, X., Synergistic effect of all-trans-retinal and triptolide encapsulated in an inflammation-targeted nanoparticle on collagen-induced arthritis in mice. Journal of controlled release : official journal of the Controlled Release Society 2020, 319, 87-103.
7. Cai, X. J.; Fei, W. D.; Xu, Y. Y.; Xu, H.; Yang, G. Y.; Cao, J. W.; Ni, J. J.; Wang, Z., Combination of metronomic administration and target delivery strategies to improve the anti-angiogenic and anti-tumor effects of triptolide. Drug delivery and translational research 2020, 10, (1), 93-107.
8. Mousavi Nejad, Z.; Torabinejad, B.; Davachi, S. M.; Zamanian, A.; Saeedi Garakani, S.; Najafi, F.; Nezafati, N., Synthesis, physicochemical, rheological and in-vitro characterization of double-crosslinked hyaluronic acid hydrogels containing dexamethasone and PLGA/dexamethasone nanoparticles as hybrid systems for specific medical applications. International journal of biological macromolecules 2019, 126, 193-208.
9. Agas, D.; Laus, F.; Lacava, G.; Marchegiani, A.; Deng, S.; Magnoni, F.; Silva, G. G.; Di Martino, P.; Sabbieti, M. G.; Censi, R., Thermosensitive hybrid hyaluronan/p(HPMAm-lac)-PEG hydrogels enhance cartilage regeneration in a mouse model of osteoarthritis. Journal of cellular physiology 2019, 234, (11), 20013-20027.
10. Kurisawa, M.; Chung, J. E.; Yang, Y. Y.; Gao, S. J.; Uyama, H., Injectable biodegradable hydrogels composed of hyaluronic acid-tyramine conjugates for drug delivery and tissue engineering. Chemical communications 2005, (34), 4312-4.
11. Burdick, J. A.; Prestwich, G. D., Hyaluronic acid hydrogels for biomedical applications. Advanced materials 2011, 23, (12), H41-56.
12. S, V.; A, S.; Annapoorna, M.; R, J.; Subramania, I.; Shantikumar, V. N.; R, J., Injectable deferoxamine nanoparticles loaded chitosan-hyaluronic acid coacervate hydrogel for therapeutic angiogenesis. Colloids and surfaces. B, Biointerfaces 2018, 161, 129-138.
13. Arun Kumar, R.; Sivashanmugam, A.; Deepthi, S.; Iseki, S.; Chennazhi, K.; Nair, S.; Jayakumar, R., Injectable Chitin-Poly(ε-caprolactone)/Nanohydroxyapatite Composite Microgels Prepared by Simple Regeneration Technique for Bone Tissue Engineering. ACS applied materials & interfaces 2015, 7, (18), 9399-409.
14. Vaca-Gonzalez, J. J.; Clara-Trujillo, S.; Guillot-Ferriols, M.; Rodenas-Rochina, J.; Sanchis, M. J.; Ribelles, J. L. G.; Garzon-Alvarado, D. A.; Ferrer, G. G., Effect of electrical stimulation on chondrogenic differentiation of mesenchymal stem cells cultured in hyaluronic acid - Gelatin injectable hydrogels. Bioelectrochemistry 2020, 134, 107536.
15. Li, C.; Cao, Z.; Li, W.; Liu, R.; Chen, Y.; Song, Y.; Liu, G.; Song, Z.; Liu, Z.; Lu, C.; Liu, Y., A review on the wide range applications of hyaluronic acid as a promising rejuvenating biomacromolecule in the treatments of bone related diseases. International journal of biological macromolecules 2020, 165, (Pt A), 1264-1275.
16. Faust, H. J.; Sommerfeld, S. D.; Rathod, S.; Rittenbach, A.; Ray Banerjee, S.; Tsui, B. M. W.; Pomper, M.; Amzel, M. L.; Singh, A.; Elisseeff, J. H., A hyaluronic acid binding peptide-polymer system for treating osteoarthritis. Biomaterials 2018, 183, 93-101.
17. An, J. Y.; Kim, K. M.; Choi, M. G.; Noh, J. H.; Sohn, T. S.; Bae, J. M.; Kim, S., Prognostic role of p-mTOR expression in cancer tissues and metastatic lymph nodes in pT2b gastric cancer. International journal of cancer 2010, 126, (12), 2904-13.
18. Racine, L.; Guliyeva, A.; Wang, I.; Larreta-Garde, V.; Auzely-Velty, R.; Texier, I., Time-Controllable Lipophilic-Drug Release System Designed by Loading Lipid Nanoparticles into Polysaccharide Hydrogels. Macromolecular bioscience 2017, 17, (9).
19. Zhao, F.; Yao, D.; Guo, R.; Deng, L.; Dong, A.; Zhang, J., Composites of Polymer Hydrogels and Nanoparticulate Systems for Biomedical and Pharmaceutical Applications. Nanomaterials 2015, 5, (4), 2054-2130.
20. Liu, X.; Gao, C.; Gu, J.; Jiang, Y.; Yang, X.; Li, S.; Gao, W.; An, T.; Duan, H.; Fu, J.; Wang, Y.; Yang, X., Hyaluronic Acid Stabilized Iodine-Containing Nanoparticles with Au Nanoshell Coating for X-ray CT Imaging and Photothermal Therapy of Tumors. ACS Appl Mater Interfaces 2016, 8, (41), 27622-27631.
21. Rao, K. M.; Kumar, A.; Suneetha, M.; Han, S. S., pH and near-infrared active; chitosan-coated halloysite nanotubes loaded with curcumin-Au hybrid nanoparticles for cancer drug delivery. International journal of biological macromolecules 2018, 112, 119-125.
22. Shakeri-Zadeh, A.; Zareyi, H.; Sheervalilou, R.; Laurent, S.; Ghaznavi, H.; Samadian, H., Gold nanoparticle-mediated bubbles in cancer nanotechnology. Journal of controlled release : official journal of the Controlled Release Society 2021, 330, 49-60.
23. Hien, N. Q.; Van Phu, D.; Duy, N. N.; Quoc le, A., Radiation synthesis and characterization of hyaluronan capped gold nanoparticles. Carbohydrate polymers 2012, 89, (2), 537-41.
24. Zhou, F.; He, X.; Iwakura, Y.; Horai, R.; Stuart, J. M., Arthritis in mice that are deficient in interleukin-1 receptor antagonist is dependent on genetic background. Arthritis and rheumatism 2005, 52, (12), 3731-8.
25. Zhou, L.; Huang, Y.; Li, J.; Wang, Z., The mTOR pathway is associated with the poor prognosis of human hepatocellular carcinoma. Medical oncology 2010, 27, (2), 255-61.
26. Kim, H.; Park, Y.; Stevens, M. M.; Kwon, W.; Hahn, S. K., Multifunctional hyaluronate - nanoparticle hybrid systems for diagnostic, therapeutic and theranostic applications. Journal of controlled release : official journal of the Controlled Release Society 2019, 303, 55-66.
27. Laragione, T.; Gulko, P. S., mTOR regulates the invasive properties of synovial fibroblasts in rheumatoid arthritis. Molecular medicine 2010, 16, (9-10), 352-8.
28. Bottini, N.; Firestein, G. S., Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nature reviews. Rheumatology 2013, 9, (1), 24-33.
29. Dai, Q.; Zhou, D.; Xu, L.; Song, X., Curcumin alleviates rheumatoid arthritis-induced inflammation and synovial hyperplasia by targeting mTOR pathway in rats. Drug design, development and therapy 2018, 12, 4095-4105.
30. Wu, X.; Long, L.; Liu, J.; Zhang, J.; Wu, T.; Chen, X.; Zhou, B.; Lv, T. Z., Gambogic acid suppresses inflammation in rheumatoid arthritis rats via PI3K/Akt/mTOR signaling pathway. Molecular medicine reports 2017, 16, (5), 7112-7118.
31. Feng, F. B.; Qiu, H. Y., Effects of Artesunate on chondrocyte proliferation, apoptosis and autophagy through the PI3K/AKT/mTOR signaling pathway in rat models with rheumatoid arthritis. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2018, 102, 1209-1220.
32. Kheirabadi, M.; Shi, L.; Bagheri, R.; Kabiri, K.; Hilborn, J.; Ossipov, D. A., In situ forming interpenetrating hydrogels of hyaluronic acid hybridized with iron oxide nanoparticles. Biomaterials science 2015, 3, (11), 1466-74.
33. Camps, M.; Ruckle, T.; Ji, H.; Ardissone, V.; Rintelen, F.; Shaw, J.; Ferrandi, C.; Chabert, C.; Gillieron, C.; Francon, B.; Martin, T.; Gretener, D.; Perrin, D.; Leroy, D.; Vitte, P. A.; Hirsch, E.; Wymann, M. P.; Cirillo, R.; Schwarz, M. K.; Rommel, C., Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nature medicine 2005, 11, (9), 936-43.
34. Lee, M.; Yang, J.; Jung, H.; Beack, S.; Choi, J.; Hur, W.; Koo, H.; Kim, K.; Yoon, S.; Hahn, S., Hyaluronic acid-gold nanoparticle/interferon α complex for targeted treatment of hepatitis C virus infection. ACS nano 2012, 6, (11), 9522-31.
35. Hynes, R., A reevaluation of integrins as regulators of angiogenesis. Nature medicine 2002, 8, (9), 918-21.
36. Meng, Q.; Xia, C.; Fang, J.; Rojanasakul, Y.; Jiang, B. H., Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway. Cellular signalling 2006, 18, (12), 2262-71.
37. Ye, E.; Loh, X. J., Polymeric Hydrogels and Nanoparticles: A Merging and Emerging Field. Australian Journal of Chemistry 2013, 66, (9), 997.
38. Shin, K.; Ryu, K.; Lee, H.; Kim, K.; Chung, H.; Sohn, D., Au nanoparticle-encapsulated hydrogel substrates for robust and reproducible SERS measurement. The Analyst 2013, 138, (3), 932-938.
39. Laroui, H.; Grossin, L.; Léonard, M.; Stoltz, J.; Gillet, P.; Netter, P.; Dellacherie, E., Hyaluronate-covered nanoparticles for the therapeutic targeting of cartilage. Biomacromolecules 2007, 8, (12), 3879-85.
40. Jin, K. M.; Kim, Y. H., Injectable, thermo-reversible and complex coacervate combination gels for protein drug delivery. Journal of controlled release : official journal of the Controlled Release Society 2008, 127, (3), 249-56.
41. Huang, Y.-Y.; Jiang, H.-X.; Shi, Q.-Y.; Qiu, X.; Wei, X.; Zhang, X.-L.; Qin, S.-Y., <p>miR-145 Inhibits Th9 Cell Differentiation by Suppressing Activation of the PI3K/Akt/mTOR/p70S6K/HIF-1α Pathway in Malignant Ascites from Liver Cancer</p>. OncoTargets and Therapy 2020, Volume 13, 3789-3800.
42. Park, H.; Yang, J.; Lee, J.; Haam, S.; Choi, I.; Yoo, K., Multifunctional nanoparticles for combined doxorubicin and photothermal treatments. ACS nano 2009, 3, (10), 2919-26.
43. Zolnik, B. S.; Leary, P. E.; Burgess, D. J., Elevated temperature accelerated release testing of PLGA microspheres. Journal of controlled release : official journal of the Controlled Release Society 2006, 112, (3), 293-300.
44. Tang, Y.; Liu, Q.; Feng, Y.; Zhang, Y.; Xu, Z.; Wen, C.; Zhang, Y., Tripterygium Ingredients for Pathogenicity Cells in Rheumatoid Arthritis. Frontiers in pharmacology 2020, 11, 583171.
45. Pantuck, A. J.; Seligson, D. B.; Klatte, T.; Yu, H.; Leppert, J. T.; Moore, L.; O'Toole, T.; Gibbons, J.; Belldegrun, A. S.; Figlin, R. A., Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy. Cancer 2007, 109, (11), 2257-67.